ArticleEpidemiologia (Basel, Switzerland)2022
The End of the Elimination Strategy: Decisive Factors towards Sustainable Management of COVID-19 in New Zealand.
Article in Epidemiologia (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed, 26 citations in OpenAlex.
- When one size does not fit all - New Zealand perspectives on the International Health Regulations during the COVID-19 pandemic.Globalization and health · 2025Article
- Article
- Is SARS-CoV-2 elimination or mitigation best? Regional and disease characteristics determine the recommended strategy.Royal Society open science · 2024Article
- Alterations of SARS-CoV-2 Evolutionary Dynamics by Pharmaceutical Factors.Infectious diseases & immunity · 2024Review
- The August 2020 COVID-19 outbreak in Aotearoa, New Zealand: Delayed contact tracing for Pacific people contributes to widening health disparities.IJID regions · 2023Article
- Tracing the international arrivals of SARS-CoV-2 Omicron variants after Aotearoa New Zealand reopened its border.Nature communications · 2022Article
- Genomic epidemiology of Delta SARS-CoV-2 during transition from elimination to suppression in Aotearoa New Zealand.Nature communications · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
New Zealand has long been praised for the effectiveness of its COVID-19 elimination strategy. It resulted in fewer COVID-19-related deaths, better economic recovery, and less stringent policy measures within its borders compared with other OECD countries, which opted for mitigation or suppression. However, since September 2021, the rising number of infections has not been contained anymore by the contact tracing and self-isolation system in place and the government has shifted towards a policy strategy similar to suppression to manage the crisis. In this case study, we analyse the factors that led the government to switch policy and discuss why elimination became unsustainable to manage the COVID-19 epidemic in New Zealand. Results showed that the socioeconomic and political factors, along with the appearance of new variants and a delayed vaccination program, were accountable for the switch in strategy. This switch allows the country to better adapt to the evolving nature of the disease and to address the social and economic repercussions of the first year of measures. Our conclusion does not disregard elimination as an appropriate initial strategy to contain this pandemic in the absence of a vaccine or treatment, but rather suggests that borders cannot remain closed for long periods of time without creating social, economical, and political issues.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.